bioRxiv / medRxiv
open access
CC BY-ND 4.0
Minimizing time in culture: A prototypic autologous manufacturing workflow for monoclonal iPSC lines within seven weeks
Induced pluripotent stem cells (iPSCs) hold great promise for both allogeneic and autologous cellular therapies. However, broad application and clinical translation is hindered by fragmented, complex and time-intensive workflows, resulting in high manufacturing costs, poor standardization and increa
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Retention-Constrained Post-Training Quantization of Cellpose-SAM for Stem Cell Microscopy#1035008
- IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG#1306972
- Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?#235408
- CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.#160363
- Analytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor#1047947
Record · ID 1181749
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive